For localized testicular cancer, the five-year survival rate is 99 percent, for regional testicular cancer, the five-year survival rate is 96 percent, and for distant testicular cancer the five-year survival rate is 73 percent, states the American Cancer Society. The higher the stage, the lower the survival rate.
The survival statistics come from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) database, states the American Cancer Society. Testicular cancer is staged using the TNM system created by the American Joint Committee on Cancer, according to the American Cancer Society. T refers to the extent of spread of the tumor to adjacent tissues, N is the spread of the cancer to nearby lymph nodes, and M stands for metastasis or spread to distant lymph nodes or distant organs in the body. Stage 1 testicular cancers generally have not spread beyond the testicle, stage 2 testicular cancers have spread to nearby lymph nodes, and stage 3 cancers have metastasized to distant organ.
The SEER database does not divide survival stages by the TNM staging system but by summary stages of localized, regional and distant testicular cancers. Stage 1 testicular cancers correspond to localized testicular cancer, stage 2 cancers correspond to regional cancer, and stage 3 cancers correspond to distant testicular cancer, explains the American Cancer Society.